company background image
A008930 logo

Hanmi Science KOSE:A008930 Stock Report

Last Price

₩32.55k

Market Cap

₩2.2t

7D

1.7%

1Y

-8.8%

Updated

24 Nov, 2024

Data

Company Financials

Hanmi Science Co., Ltd.

KOSE:A008930 Stock Report

Market Cap: ₩2.2t

A008930 Stock Overview

Through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. More details

A008930 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

Hanmi Science Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hanmi Science
Historical stock prices
Current Share Price₩32,550.00
52 Week High₩56,200.00
52 Week Low₩25,750.00
Beta0.87
11 Month Change-20.02%
3 Month Change3.01%
1 Year Change-8.82%
33 Year Change-37.63%
5 Year Change-9.54%
Change since IPO6,946.20%

Recent News & Updates

Is Hanmi Science (KRX:008930) Using Too Much Debt?

Nov 14
Is Hanmi Science (KRX:008930) Using Too Much Debt?

Recent updates

Is Hanmi Science (KRX:008930) Using Too Much Debt?

Nov 14
Is Hanmi Science (KRX:008930) Using Too Much Debt?

Hanmi Science Co., Ltd. (KRX:008930) Looks Just Right With A 27% Price Jump

Oct 27
Hanmi Science Co., Ltd. (KRX:008930) Looks Just Right With A 27% Price Jump

Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)

Aug 30
Returns On Capital Are Showing Encouraging Signs At Hanmi Science (KRX:008930)

Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly

Aug 13
Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly

Hanmi Science Co., Ltd. (KRX:008930) Not Flying Under The Radar

Jul 22
Hanmi Science Co., Ltd. (KRX:008930) Not Flying Under The Radar

Is Hanmi Science (KRX:008930) Using Too Much Debt?

Apr 29
Is Hanmi Science (KRX:008930) Using Too Much Debt?

Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Jan 31
Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt

Jan 05
We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt

Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%

Dec 06
Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%

Shareholder Returns

A008930KR HealthcareKR Market
7D1.7%5.9%2.9%
1Y-8.8%-5.5%-2.8%

Return vs Industry: A008930 underperformed the KR Healthcare industry which returned -5.5% over the past year.

Return vs Market: A008930 underperformed the KR Market which returned -2.8% over the past year.

Price Volatility

Is A008930's price volatile compared to industry and market?
A008930 volatility
A008930 Average Weekly Movement14.1%
Healthcare Industry Average Movement7.8%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A008930's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A008930's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1973403Jong-Hoon Limwww.hanmiscience.co.kr

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment.

Hanmi Science Co., Ltd. Fundamentals Summary

How do Hanmi Science's earnings and revenue compare to its market cap?
A008930 fundamental statistics
Market cap₩2.20t
Earnings (TTM)₩104.96b
Revenue (TTM)₩1.28t

21.0x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A008930 income statement (TTM)
Revenue₩1.28t
Cost of Revenue₩986.45b
Gross Profit₩297.20b
Other Expenses₩192.24b
Earnings₩104.96b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.55k
Gross Margin23.15%
Net Profit Margin8.18%
Debt/Equity Ratio25.3%

How did A008930 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

13%

Payout Ratio

Does A008930 pay a reliable dividends?

See A008930 dividend history and benchmarks
When do you need to buy A008930 by to receive an upcoming dividend?
Hanmi Science dividend dates
Ex Dividend DateDec 27 2024
Dividend Pay DateApr 14 2025
Days until Ex dividend32 days
Days until Dividend pay date140 days

Does A008930 pay a reliable dividends?

See A008930 dividend history and benchmarks